PCI Biotech Holding — Director's Dealing 2016

Dec 14, 2016

PCI Biotech: Mandatory notification of trade

PCI Biotech: Mandatory notification of trade

The Chairman Hans Peter Bøhn has today, 14 December 2016, subscribed for 33.556

new shares in PCI Biotech Holding ASA (the "Company") at a subscription price of

NOK 7 per share by exercising 33.556 subscription rights in the Company's

ongoing rights issue. After the transaction, Hans Peter Bøhn will have a total

shareholding in the company of 83.556 shares and 0 subscription rights in the

rights issue. Hans Peter Bøhn has previously entered into a guarantee agreement

of NOK 1 000 000 in relation to the rights issue, and todays exercise of

subscription rights will, in compliance with the guarantee agreement, reduce the

guarantee liability correspondingly.

Contact information:

PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo

Ronny Skuggedal, CFO, rs@pcibiotech.no, Mobile: +47 9400 5757

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.